Latest EOI From Kazakh

Medicines with the Active Ingredient Ciclosporin (Atc: S01xa18)

Medicines with the Active Ingredient Tafluprost (Atc: S01ee05)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Formoterol Beclometasone (Exclusively Dafo. Ihp, Inh), Atc R03ak08 for the Period January 1St, 2024 - December 31St, 2025

Day & Evening Services

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Order Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Filgrastim and the Trade Name Zarzio / Filgrastim Hexal

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Conclusion not Excluding Drug Discount Agreement. in Accordance with Section 130A Paragraph 8 Sgb V Iwe Open House Model for the Active Ingredient Calcipotriol/Betamethasone (Atc Code who D05ax52), Limited to the Gel Administration

Contract Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Filgrastim and the Trade Name Neupogen(R)

Open House Reintegration